GABA is the primary inhibitory neurotransmitter in the brain — the "calm down" signal. Supplemental GABA is widely sold for anxiety and sleep, but our research shows a fundamental problem: oral GABA poorly crosses the blood-brain barrier, questioning whether supplements meaningfully affect brain GABA levels. Some studies show anxiolytic effects (possibly via the enteric nervous system or limited BBB penetration), but the mechanism remains debated.
GABA (gamma-aminobutyric acid) is a non-protein amino acid that acts as the primary inhibitory neurotransmitter. It reduces neuronal excitability by binding GABA-A (ionotropic) and GABA-B (metabotropic) receptors. Benzodiazepines, barbiturates, and alcohol all work by enhancing GABA activity.
The BBB controversy: Classic pharmacology teaches that GABA doesn't cross the blood-brain barrier in meaningful amounts. However: (1) some studies show EEG changes after oral GABA, (2) GABA may act on peripheral GABA receptors in the enteric nervous system (gut-brain axis), (3) PharmaGABA (naturally produced via Lactobacillus hilgardii fermentation) may have slightly better absorption than synthetic GABA.
Both enhance GABAergic activity — additive sedation
Additive CNS depression
Different mechanism but related to GABA system; monitor for additive sedation
GABA may lower blood pressure
Additive CNS depression
Not Prohibited
Abdou AM et al. Relaxation and immunity enhancement effects of GABA administration.
Boonstra E et al. Neurotransmitters as food supplements: the effects of GABA on brain and behavior.
Yamatsu A et al. Effect of oral gamma-aminobutyric acid on sleep.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated: April 2026
Not medical advice. Based on published clinical research and systematic reviews.